MetaCap

Electra Therapeutics Earnings

NASDAQ: ETRAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

8.11-0.83 (-9.28%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Electra Therapeutics earnings summary

In its most recent report on Nov 12, 2026 (Sep/2026), ETRA posted EPS of $-3.47 versus the $-1.76 consensus estimate, a negative surprise of 97.2%.

Summary generated from market data by MetaCap's automated system. Methodology

ETRA earnings history

Electra Therapeutics reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Nov 12, 2026$-1.76$-3.47-97.2%-8.3%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related